The Future of COVID-19: Living with an Endemic Disease

COVID-19 has reshaped the world in profound ways over the past few years, but as we progress into 2025, the focus is shifting from pandemic to endemic. This transition means that COVID-19 will likely remain a part of our lives, but in a more predictable, manageable way. Understanding how we live with COVID-19 as an endemic disease is key to mitigating its impact on public health and daily life.

COVID-19 Rapid Testing: What to Do if You Test Positive

At-home rapid testing makes it possible to know your infection status quickly and monitor your health over time. So What Should I Do If I Am Positive?

Is It OK to Stop Worrying about COVID?

A recent article from BU Today, Boston University’s daily news website, posed the question, is it OK to stop worrying about COVID? This shift in mindset doesn’t mean ignoring COVID-19; instead, it involves adapting our approach to fit the current reality.

The Importance of Rapid COVID-19 Testing in Routine Vaccination Strategies

The fight against COVID-19 has entered a new phase in 2024, one in which vaccinations have become “routine”, like an annual flu shot.

Predicted Seasonal Surges of COVID-19 in the Winter of 2024

Rapid testing remains our primary way to remain vigilant against new variant outbreaks and spreading of the virus during seasonal trends which hit in waves.

Rapid Testing and Stemming COVID-19 Spread During the Winter of 2024

As we enter the winter of 2024, concerns over COVID-19 transmission are heightened due to increased indoor activities, increased travel and holiday-related gatherings,  and prevalence of other seasonal respiratory illnesses.

PRESS RELEASE | Oceanit’s ASSURE-100 Rapid COVID-19 Home Test Receives FDA Over-The-Counter Authorization

On December 22, 2022, Oceanit’s ASSURE-100 received FDA Over-The-Counter authorization. The ASSURE-100 Rapid COVID-19 Home Test authorization, an over-the-counter home test, comes ten months after initial point-of-care EUA was granted on February 28, 2022.